Skip navigation Jump to main navigation

Advisory Regarding Coronavirus COVID-19

In order to deliver the best and safest program for our students, the School of Professional Studies is planning to move all programs to online learning for Summer 2020. With the State of New York’s approval, we expect to formally announce this transition as of April 10, 2020. We are excited to deliver dynamic and engaging courses and cocurricular activities online. Our websites will be updated with additional details in the coming weeks. Learn More.
Close alert

Amrit Ray, M.D.

Global President, R&D, Pfizer Essential Health

Dr. Amrit Ray is the Global President, R&D and Medical, for Pfizer's Upjohn business. Previously, he was the Global President, R&D, where he was responsible for an R&D organization supporting both a rich R&D pipeline and an unrivaled on market portfolio of over 600 medicines.

Before joining Pfizer, Dr. Ray was at Johnson & Johnson where he served as global Chief Medical Officer for pharmaceuticals, and previously as Chief Safety Officer. Prior to J&J, Dr. Ray held positions of increasing R&D responsibilities in Clinical Development, Safety & Epidemiology, and Medical Affairs at Pfizer and Bristol-Myers Squibb.

By background, Dr. Ray is an experienced physician-researcher and business leader with a track record of championing medical innovation. Dr. Ray earned Immunology and Medical degrees from Edinburgh Medical School. Following antibody bench research at Sir Joseph Lister Labs, obesity clinical research at the Mayo Clinic, and clinical training at Edinburgh Royal Infirmary, he began his career serving as a hospital doctor delivering patient care in Britain's National Health Service. Dr. Ray's business experience comes as a former McKinsey consultant focusing on corporate finance, and from earning an MBA at Dartmouth's Tuck School of Business.